The Effectiveness of Lower Cyclosporine Doses for Psoriasis
Status:
Withdrawn
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
This study will evaluate whether lower doses of cyclosporine can cause fewer side effects and
still produce the same beneficial results that are seen with a standard cyclosporine dose
regimen when treating individuals with moderate to severe psoriasis.
Phase:
Phase 2
Details
Lead Sponsor:
University of Rochester
Collaborator:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)